Ivar Bleumer

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

Ivar Bleumer, Alexander Knuth, Egbert Oosterwijk et al. · British Journal of Cancer · 2004 · 173 citations · Full text

Medicine, Oncology, Pharmacology +17

Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study

Jeannette Oosterwijk‐Wakka, Dorien M. Tiemessen, Ivar Bleumer et al. · Journal of Immunotherapy · 2002 · 99 citations · Full text

Medicine, Immunology, Oncology +17

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

Ivar Bleumer, Egbert Oosterwijk, Jeannette Oosterwijk‐Wakka et al. · The Journal of Urology · 2005 · 92 citations

Medicine, Oncology, Pharmacology +17

Validation of an Integrated Staging System Toward Improved Prognostication of Patients With Localized Renal Cell Carcinoma in an International Population

Ken‐ryu Han, Ivar Bleumer, Allan J. Pantuck et al. · The Journal of Urology · 2003 · 76 citations

Medicine, Oncology, Urology +16

Preliminary Analysis of Patients With Progressive Renal Cell Carcinoma Vaccinated With CA9-peptide–Pulsed Mature Dendritic Cells

Ivar Bleumer, Dorien M. Tiemessen, Jeannette Oosterwijk‐Wakka et al. · Journal of Immunotherapy · 2006 · 56 citations

Medicine, Immunology, Oncology +17